Otezla and Prostatitis - a phase IV clinical study of FDA data

Summary:

Prostatitis is found among people who take Otezla, especially for people who are 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Otezla and have Prostatitis. It is created by eHealthMe based on reports of 133,724 people who have side effects when taking Otezla from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

133,724 people reported to have side effects when taking Otezla.
Among them, 7 people (0.01%) have Prostatitis.

What is Otezla?

Otezla has active ingredients of apremilast. It is often used in psoriatic arthritis. eHealthMe is studying from 133,894 Otezla users for its effectiveness, alternative drugs and more.

What is Prostatitis?

Prostatitis (inflammation of the prostate gland) is found to be associated with 1,023 drugs and 521 conditions by eHealthMe.

Number of Otezla and Prostatitis reports submitted per year:

Time on Otezla when people have Prostatitis *:

Age of people who have Prostatitis when taking Otezla *:

Common drugs people take besides Otezla *:

Amlodipine: 2 people, 28.57%
Norvasc: 1 person, 14.29%
Hctz: 1 person, 14.29%
Flomax: 1 person, 14.29%
Asa: 1 person, 14.29%

Common side effects people have besides Prostatitis *:

Diarrhea: 3 people, 42.86%
Kidney Infection (Pyelonephritis): 2 people, 28.57%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 14.29%
Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 1 person, 14.29%
Nausea (feeling of having an urge to vomit): 1 person, 14.29%
Drug Ineffective: 1 person, 14.29%

Common conditions people have *:

Psoriasis (immune-mediated disease that affects the skin): 7 people, 100.00%
Thyroid Diseases: 1 person, 14.29%
High Blood Cholesterol: 1 person, 14.29%
Enlarged Prostate: 1 person, 14.29%
Depression: 1 person, 14.29%
Cardiac Disorder: 1 person, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Otezla and have Prostatitis?

Check whether Prostatitis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Prostatitis and when was it recovered:

Prostatitis in Otezla

Expand to all the drugs that have ingredients of apremilast:

Prostatitis and drugs with ingredients of apremilast

Alternative drugs to, pros and cons of Otezla:

Otezla (133,894 reports)

Common Otezla side effects:

Diarrhea: 24,088 reports
Psoriasis (immune-mediated disease that affects the skin): 19,845 reports
Headache (pain in head): 16,774 reports
Drug ineffective: 13,458 reports
Rashes (redness): 5,487 reports
Joint pain: 4,394 reports

Browse all side effects of Otezla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Prostatitis treatments and more:

Prostatitis (7,119 reports)

COVID vaccines that are related to Prostatitis:

Common drugs associated with Prostatitis:

All the drugs that are associated with Prostatitis:

Prostatitis (1,023 drugs)

Common conditions associated with Prostatitis:

All the conditions that are associated with Prostatitis:

Prostatitis (521 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on apremilast (the active ingredients of Otezla) and Otezla (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.